2011 Autumn Conference
03 – 04 October, 2011 // Amelia Island, Florida USA
Poster Awardee: |
||
Detecting Antidepressant Efficacy: The Impact of Study Design and the Value of Academic Sites BW Dunlop, ME Thase, C Wun, R Fayyad, C Guico-Pabia, J.Musgnung, PT Ninan |
||
All poster abstracts are available for public viewing. Link found at end of Day 1 | ||
Day 1 (3 October 2011) |
||
President’s Welcome | L Alphs![]() ![]() |
|
Session 1: Meta Analysis: Methods and Applications to Policy | Chairs: A Leon V Haynes SESSION SUMMARY |
|
Frequentist Methods of Meta Analysis | M Borenstein![]() ![]() |
|
Bayesian Methods and Meta Analysis | J Seaman![]() ![]() |
|
“Proof” in Medicine: The Role of Research Synthesis | J Greenhouse![]() ![]() |
|
Impact of Meta Analysis for Policy Decisions About Reimbursement – Payer Perspective | R Robinson-Beale![]() ![]() |
|
Discussant | J Davis | |
Comments and Panel Discussion | ![]() |
|
Session 2: Concurrent Workshops | ||
WS1: How Can Large Registries Contribute to the Development and Evaluation of CNS Therapeutics? |
J Severe A Stemhagen ![]() ![]() |
|
WS2: Evaluating Biomarkers for Schizophrenia: Issues in Identification, Categorization and Evaluation |
N Chen
S De Santi
S Potkin
H Riordan
|
|
WS3: Assessing Assessment Methodologies: Weighing Choices Based on Indications, Study Design and Needs |
M Davidson
M Detke
|
|
WS4: Suicidal Ideation and Behavior Assessment: Implementation in Clinical Trials |
A Butler
M Stewart
|
|
WS5: Adaptive Design in CNS Trials |
V Dragalin
J Pinheiro
V Haynes
|
|
Plenary Workshop Reports | ||
Poster Session | View All Poster Abstracts | |
Day 2 (4 October 2011) |
||
Session 3: Beyond Insomnia: Issues in Non-restorative Sleep | Chairs: T Macek T Roth |
|
An Overview of Non-restorative Sleep | T Roth![]() ![]() |
|
Measuring Non-restorative Sleep | R Morlock![]() ![]() |
|
Issues in Conducting Trials in Non-restorative Sleep | V Pitman![]() ![]() |
|
Regulatory Perspectives on Non-restorative Sleep | R Katz![]() ![]() ![]() ![]() ![]() |
|
Session 4: Clinical Trials for Alcohol Dependence: The Alcohol Clinical Trials Initiative (ACTIVE) and Beyond | Chairs: N Schooler R Anton |
|
Rationale and Development of the ACTIVE Workgroup | R Anton![]() ![]() |
|
Evolution of FDA Approach to Clinical Trials for Alcohol Treatment Drugs | C Winchell![]() ![]() |
|
Outcomes and Endpoints in European Clinical Trials for Alcohol Dependence – Focus on Harm Reduction | K Broich![]() ![]() ![]() |
|
Challenges to Industry in the Development of Pharmacological Therapies for the Treatment of Alcohol Abuse and Dependence | J Palumbo![]() ![]() |
|
Novel Reanalyses of Alcohol Treatment Endpoints in US Clinical Trials to Inform Methodologies | R Litten![]() ![]() |
|
Comments and Panel Discussion | R Meyer![]() ![]() |
|
Panel and Audience Discussion | ![]() |
|
Meeting Adjourns |